GlassScriptPhysician profile
Anjali Gupta
NPI 1982145074
$1,327.60
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.38 · 2020: $138 · 2021: $520 · 2022: $524 · 2023: $74.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.25 | 2020-2023 | |
| Pfizer INC. | $117.80 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.87 | 2020-2022 | |
| Exeltis, USA INC. | $89.26 | 2019-2022 | |
| Coopersurgical, INC. | $76.19 | 2021-2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $73.21 | 2021-2022 | |
| Therapeuticsmd, INC. | $46.79 | 2019-2022 | |
| Shield Therapeutics INC | $45.36 | 2022 | |
| Organon LLC | $42.71 | 2021 | |
| Daiichi Sankyo INC. | $41.91 | 2022 | |
| Allergan, INC. | $38.80 | 2019-2020 | |
| Evofem Biosciences, INC. | $33.73 | 2021-2022 | |
| Trevena, INC. | $32.90 | 2021 | |
| Merck Sharp & Dohme LLC | $24.58 | 2021 | |
| Amag Pharmaceuticals, INC. | $23.83 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $20.97 | 2021 | |
| Mylan Pharmaceuticals INC. | $18.83 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.66 | 2019 | |
| Argon Medical Devices, INC. | $15.95 | 2023 | Cleaner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.